Psychemedics Corporation Announces 4th Quarter and Year-End Results ACTON, Mass., Feb. 11, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced fourth quarter and year-end financial results for the period ended December 31, 2019.  The...

Psychemedics Announces Second Quarter Results and Declares 92nd Consecutive Quarterly Dividend ACTON, Mass., July 23, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced second quarter financial results for the period ended June 30, 2019.  The Company also announced...

Psychemedics Test for Fentanyl Detection Cleared by FDA ACTON, Mass., April 24, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced the industry’s...